Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,215 | Dovepress* | 3,901+ | 580 | 4,481 | |
| PubMed Central* | 314 | 106 | 420 | ||
| Totals | 4,215 | 686 | 4,901 | ||
| *Since 9 December 2020 | |||||
View citations on PubMed and Google Scholar